| RS1064795693 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795694 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1064795696 |
TRPV4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease axonal type 2C |
| RS1064795698 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064795700 |
BAG3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795702 |
FHL1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795703 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS1064795705 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1064795707 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795711 |
SCN11A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795712 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
GRIN1-related disorder, GRIN1-related disorder |
| RS1064795716 |
RAD51D
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1064795718 |
NPC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Niemann-Pick disease, type C1 |
| RS1064795719 |
CHRND
|
Health Risk |
Likely pathogenic |
Lethal multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS1064795720 |
NSD1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795722 |
CDH23
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS1064795724 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1064795725 |
IQSEC2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795726 |
RERE
|
Health Risk |
Likely pathogenic |
— |
| RS1064795728 |
AGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS1064795729 |
BMPR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1064795730 |
NF1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795731 |
CDK13
|
Health Risk |
Pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1064795732 |
SETD5
|
Health Risk |
Likely pathogenic |
— |
| RS1064795733 |
SCN1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064795734 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1064795735 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1064795736 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795738 |
TUBA1A
|
Health Risk |
Likely pathogenic |
Tubulinopathy, Tubulinopathy |
| RS1064795739 |
EYA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795743 |
OPA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795748 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS1064795749 |
PFKM
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VII |
| RS1064795750 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy, limb-girdle |
| RS1064795751 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795753 |
ZC4H2
|
Health Risk |
Likely pathogenic |
Wieacker-Wolff syndrome, female-restricted |
| RS1064795754 |
RIGI
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064795756 |
SCN1A
|
Health Risk |
Likely pathogenic |
— |
| RS1064795757 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS1064795758 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1064795759 |
SHANK3
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1064795760 |
BICD2
|
Health Risk |
Pathogenic/Likely pathogenic |
14 conditions, Spinal muscular atrophy |
| RS1064795761 |
KMT2C
|
Health Risk |
Likely pathogenic |
— |
| RS1064795762 |
PIK3CD
|
Health Risk |
Pathogenic |
Immunodeficiency 14, Immunodeficiency 14 |
| RS1064795764 |
BICD2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795769 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795770 |
COL12A1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795771 |
MAP3K7
|
Health Risk |
Likely pathogenic |
— |
| RS1064795772 |
SLC25A46
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Neuropathy |
| RS1064795774 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1064795775 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795778 |
EXT1
|
Health Risk |
Pathogenic |
— |
| RS1064795779 |
CACNA1E
|
Health Risk |
Likely pathogenic |
— |
| RS1064795783 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Familial cancer of breast |
| RS1064795784 |
SCN5A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064795785 |
GJB1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795786 |
BAP1
|
Health Risk |
Pathogenic |
— |
| RS1064795789 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795790 |
MSH6
|
Health Risk |
Pathogenic |
Lynch syndrome 5, Lynch syndrome 5 |
| RS1064795792 |
APC
|
Health Risk |
Pathogenic |
— |
| RS1064795793 |
KCNC3
|
Health Risk |
Likely pathogenic |
— |
| RS1064795794 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1064795797 |
GLRA1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795798 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS1064795800 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 6, Developmental and epileptic encephalopathy |
| RS1064795801 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
— |
| RS1064795802 |
ALG11
|
Health Risk |
Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS1064795803 |
ALG11
|
Health Risk |
Likely pathogenic |
ALG11-congenital disorder of glycosylation, ALG11-congenital disorder of glycosylation |
| RS1064795805 |
GABRA1
|
Health Risk |
Likely pathogenic |
Idiopathic generalized epilepsy, Epilepsy |
| RS1064795806 |
IQSEC2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795809 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CHARGE syndrome |
| RS1064795810 |
OTX2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795811 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064795812 |
DEAF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-epilepsy-extrapyramidal syndrome, Intellectual disability-epilepsy-extrapyramidal syndrome |
| RS1064795813 |
DEAF1
|
Health Risk |
Pathogenic |
Intellectual disability-epilepsy-extrapyramidal syndrome, Intellectual disability-epilepsy-extrapyramidal syndrome |
| RS1064795815 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1064795816 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS1064795817 |
SATB2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795818 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1064795821 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1064795824 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1064795825 |
HIVEP2
|
Health Risk |
Likely pathogenic |
— |
| RS1064795826 |
FBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fructose-biphosphatase deficiency, Fructose-biphosphatase deficiency |
| RS1064795831 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1064795832 |
SCN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1064795833 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS1064795834 |
PCDH19
|
Health Risk |
Likely pathogenic |
— |
| RS1064795835 |
CHRNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 2A, Congenital myasthenic syndrome 2A |
| RS1064795836 |
CD36
|
Health Risk |
Likely pathogenic |
— |
| RS1064795837 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1064795838 |
NPRL3
|
Health Risk |
Likely pathogenic |
Epilepsy, familial focal |
| RS1064795839 |
COLQ
|
Health Risk |
Likely pathogenic |
— |
| RS1064795840 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795842 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Intellectual disability |
| RS1064795843 |
TMEM67
|
Health Risk |
Likely pathogenic |
— |
| RS1064795844 |
GNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1064795845 |
CDC42
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Neurodevelopmental abnormality |
| RS1064795851 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1064795852 |
SLC6A1
|
Health Risk |
Likely pathogenic |
Epilepsy with myoclonic atonic seizures, Inborn genetic diseases |
| RS1064795854 |
FLNA
|
Health Risk |
Likely pathogenic |
— |